Geron reported $151.55M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Amgen AMGN:US $ 8217M 30M
Aurinia Pharmaceuticals Inc AUP:CN 332.26M 37.97M
Bio Techne TECH:US $ 1646.96M 83.98M
Cti Biopharma CTIC:US $ 38.89M 22.82M
Cytokinetics CYTK:US $ 249.02M 232.53M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Exelixis EXEL:US $ 2112.45M 69.37M
Genmab GEN:DC DK 21285M 1033M
Geron GERN:US $ 151.55M 24.65M
Gilead Sciences GILD:US $ 21471M 1768M
Macrogenics MGNX:US $ 291.44M 27.61M
Novartis NOVN:VX SF 56771M 2729M
Novavax NVAX:US $ 461.34M 284.23M
Pain Therapeutics PTIE:US $ 267.56M 8.91M
Seattle Genetics SGEN:US $ 3164.96M 226.32M
YTE INCY:US $ 3148.66M 212.8M